Evidence map›Paper›PMID 25257529›Full record

ArticleInternational journal of molecular sciences2014

Triethanolamine stabilization of methotrexate-β-cyclodextrin interactions in ternary complexes.

Jahamunna A A Barbosa, Ariana Zoppi, Mario A Quevedo, Polyanne N de Melo, Arthur S A de Medeiros, Letícia Streck, Alice R de Oliveira, Matheus F Fernandes-Pedrosa, Marcela R Longhi, Arnóbio A da Silva-Júnior

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 44 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Jahamunna A A BarbosaGraduate Program on Pharmaceutical Sciences, Department of Pharmacy, Federal University of Rio Grande do Norte (UFRN), Av. General Gustavo Cordeiro de Farias, Petrópolis, 59072-570 Natal, Brazil. jamunauepb@gmail.com.
Ariana ZoppiResearch and Pharmaceutical Technology Development Unit (UNITEFA, CONICET-UNC) and Department of Pharmacy, Faculty of Chemical Sciences, National University of Córdoba, Ciudad Universitaria, X5000HUA Córdoba, Argentina. ariana@fcq.unc.edu.ar.
Mario A QuevedoResearch and Pharmaceutical Technology Development Unit (UNITEFA, CONICET-UNC) and Department of Pharmacy, Faculty of Chemical Sciences, National University of Córdoba, Ciudad Universitaria, X5000HUA Córdoba, Argentina. alfredoq@fcq.unc.edu.ar.
Polyanne N de MeloGraduate Program on Development and Technologic Innovation in Pharmaceuticals, UFRN, Av. Salgado Filho, 3000-Lagoa Nova, 59072-970 Natal, Brazil. polyanne_melo86@yahoo.com.br.
Arthur S A de MedeirosGraduate Program on Pharmaceutical Sciences, Department of Pharmacy, Federal University of Rio Grande do Norte (UFRN), Av. General Gustavo Cordeiro de Farias, Petrópolis, 59072-570 Natal, Brazil. arthurmedeiros@ymail.com.
Letícia StreckGraduate Program on Development and Technologic Innovation in Pharmaceuticals, UFRN, Av. Salgado Filho, 3000-Lagoa Nova, 59072-970 Natal, Brazil. leticiastreck@gmail.com.
Alice R de OliveiraGraduate Program on Healthy Sciences, UFRN, Av. General Gustavo Cordeiro de Farias, Petrópolis, 59072-570 Natal, Brazil. farmalix@yahoo.com.br.
Matheus F Fernandes-PedrosaGraduate Program on Pharmaceutical Sciences, Department of Pharmacy, Federal University of Rio Grande do Norte (UFRN), Av. General Gustavo Cordeiro de Farias, Petrópolis, 59072-570 Natal, Brazil. mpedrosa@ufrnet.br.
Marcela R LonghiResearch and Pharmaceutical Technology Development Unit (UNITEFA, CONICET-UNC) and Department of Pharmacy, Faculty of Chemical Sciences, National University of Córdoba, Ciudad Universitaria, X5000HUA Córdoba, Argentina. mrlcor@fcq.unc.edu.ar.
Arnóbio A da Silva-JúniorGraduate Program on Pharmaceutical Sciences, Department of Pharmacy, Federal University of Rio Grande do Norte (UFRN), Av. General Gustavo Cordeiro de Farias, Petrópolis, 59072-570 Natal, Brazil. arnobiosilva@ufrnet.br.
Universidade Federal do Rio Grande do Norte · BRConsejo Nacional de Investigaciones Científicas y Técnicas · AR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The interaction of methotrexate (MTX) with beta-cyclodextrin (β-CD) in the presence of triethanolamine (TEA) was investigated with the aim to elucidate the mechanism whereby self-assembly cyclodextrin systems work in association with this third component. Solubility diagram studies showed synergic increment of the MTX solubility to be about thirty-fold. Experiments using 2D ROESY and molecular modeling studies revealed the inclusion of aromatic ring III of the drug into β-CD cavity, in which TEA contributes by intensifying MTX interaction with β-CD and stabilizes MTX:β-CD:TEA ternary complex by electrostatic interaction. The maintenance of these interactions in solid phase was also studied in ternary MTX:β-CD:TEA and comparisons were made with freeze dried binary MTX:β-CD and physical mixtures. FTIR studies evidenced that MTX-β-CD interaction remained in solid ternary complexes, which was also supported by thermal (differential scanning calorimetry (DSC), thermogravimetric analysis (TG)/first derivative of TG analysis (DTG) and C,N,H elementary analysis) and structural (X-ray diffraction analysis, (XRD)) studies, mainly regarding the increment of drug stability. The efficient in vitro drug dissolution studies successfully demonstrated the contribution of ternary complexes, which highlights the importance of this possible new raw material for further applications in drug delivery systems.

Indexed as

beta-CyclodextrinsCalorimetry, Differential ScanningCrystallography, X-RayDrug CarriersEthanolaminesExcipientsFreeze DryingHydrophobic and Hydrophilic InteractionsMethotrexateMolecular Docking SimulationMolecular Dynamics SimulationSolubilitySpectroscopy, Fourier Transform InfraredStatic ElectricityThermogravimetryWaterbeta-CyclodextrinsbetadexDrug CarriersEthanolaminesExcipientsMethotrexatetriethanolamineWater

Identifiers

PMID25257529
PMCPMC4200828
OpenAlexW2027907003

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.